Literature DB >> 29189190

Role of Repetitive Transcranial Magnetic Stimulation (rTMS) in Treatment of Addiction and Related Disorders: A Systematic Review.

Ramkrishna Makani1, Basant Pradhan2, Umang Shah1, Tapan Parikh1.   

Abstract

BACKGROUND: Addiction and related disorders are devastating with their tremendous social, psychological, and physical consequences for which development of optimally effective treatments is long overdue. Repetitive Transcranial Magnetic Stimulation (rTMS) is relatively safe and is becoming an emerging therapeutic tool for these conditions.
METHODS: This systematic review was conducted using PubMed, PsycINFO, PsychiatryOnline and Cochrane Library ranging from year 2001 to 2017.
RESULTS: Our search selected 70 related articles of which, based on the Strength of Recommendation Taxonomy (SORT) guidelines, 11 indicated Level-1 study quality and class-B strength of recommendation for rTMS in nicotine addiction (effective in 218/289 subjects who received rTMS as found in 11 studies). Level-2/Class-B evidence was found for alcohol and cocaine addictions (Alcohol: effective in 126/193 subjects who received rTMS as found in 8 studies; Cocaine: effective in 86/128 subjects, as found in 5 studies). For food cravings, Level-3/Class-B evidence was noted (effective in 134/169, found in 7 studies). However, the evidence was limited to Level-3/Class-C for heroin (10/20 subjects received active rTMS, effective in 1 study), methamphetamine (33/48 subjects received active rTMS, effective in 2 studies), cannabis (18/18 subjects received active rTMS, effective in 1 study), and pathological gambling (31/31 subjects received active rTMS, effective in 2 studies).
CONCLUSION: rTMS may serve as an emerging therapeutic option for addiction and related disorders. The major lacunae include important methodological limitations and dearth of knowledge about precise mechanism of action that need to be addressed in the future studies. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Drug dependence; addiction treatment; behavioral addiction; brain stimulation; drug cravings; neurobiology; pre-frontal cortex; rTMS.

Mesh:

Year:  2017        PMID: 29189190     DOI: 10.2174/1874473710666171129225914

Source DB:  PubMed          Journal:  Curr Drug Abuse Rev        ISSN: 1874-4737


  6 in total

1.  Death by Opioids: Are there non-addictive scientific solutions?

Authors:  B William Downs; Kenneth Blum; David Baron; Abdalla Bowirrat; Lisa Lott; Raymond Brewer; Brent Boyett; David Siwicki; A Kenison Roy; Arwen Podesta; Sampada Badgaiyan; Raju Hajela; Lyle Fried; Rajendra D Badgaiyan
Journal:  J Syst Integr Neurosci       Date:  2019-10-31

Review 2.  Transcranial magnetic stimulation for the treatment of cocaine addiction: evidence to date.

Authors:  Corinna Bolloni; Paola Badas; Giorgio Corona; Marco Diana
Journal:  Subst Abuse Rehabil       Date:  2018-05-21

3.  Adjuvant treatment with repetitive transcranial magnetic stimulation in freshly diagnosed alcohol-dependence syndrome patients from an industry: An outcome study.

Authors:  Anindya Kumar Gupta; Amit Kumar; N Chandrashekhar
Journal:  Ind Psychiatry J       Date:  2021-10-22

4.  Portable Neuroimaging-Guided Noninvasive Brain Stimulation of the Cortico-Cerebello-Thalamo-Cortical Loop-Hypothesis and Theory in Cannabis Use Disorder.

Authors:  Pushpinder Walia; Abhishek Ghosh; Shubhmohan Singh; Anirban Dutta
Journal:  Brain Sci       Date:  2022-03-26

5.  A sham-controlled trial of repetitive transcranial magnetic stimulation over left dorsolateral prefrontal cortex and its effects on craving in patients with alcohol dependence.

Authors:  Shashank Raikwar; K J Divinakumar; Jyoti Prakash; Shahbaaz Ali Khan; K V GuruPrakash; Silvi Batham
Journal:  Ind Psychiatry J       Date:  2021-03-15

6.  Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual.

Authors:  Kenneth Blum; Lisa Lott; David Baron; David E Smith; Rajendra D Badgaiyan; Mark S Gold
Journal:  J Syst Integr Neurosci       Date:  2020-05-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.